From Coffee Husk to Brain Health: The Science Behind Iom Bioworks' Prebiotic Push

Why It Matters

Scaling a waste‑to‑wellness pipeline could lower supplement costs, boost India’s biotech growth, and provide a scientifically grounded product for the expanding gut‑brain market.

Key Takeaways

• Iom Bioworks extracts pectic oligosaccharides from coffee husk
• POS resist stomach acid, feeding beneficial gut bacteria
• Seed round raised ~US$480,000, supporting scale‑up
• Two patents granted; two more pending approval

Pulse Analysis

The gut‑brain axis has moved from fringe wellness talk to a research frontier, linking microbiome composition to mood, sleep and stress. As global interest in functional foods surges, the Indian biotech sector—projected to hit $300 billion by 2030—seeks scalable, science‑backed solutions. Turning agricultural waste into high‑value ingredients aligns with sustainability trends and offers a cost advantage in a market where consumers demand evidence‑based products.

Iom Bioworks differentiates itself by pairing microbiome sequencing with AI‑driven modeling to personalize prebiotic recommendations. Its portfolio already includes DNA‑based tests for PCOS and targeted blends for sleep and stress, all produced under ISO 9001 and ISO 27001 certifications. Leadership includes biotech veteran Dr Samik Ghosh and systems‑biology pioneer Dr Hiroaki Kitano, whose experience at Sony AI adds credibility. The company’s recent seed funding—approximately $480,000—will fund the industrialisation of its coffee‑husk POS process, leveraging two granted patents and two pending applications.

If Iom can scale the conversion of coffee husk—a plentiful by‑product of India’s coffee industry—into a low‑cost prebiotic, it could create a triple win: reducing farm waste, offering an affordable brain‑health supplement, and strengthening India’s position in the global nutraceutical arena. The next critical step is robust human clinical data to move POS from promising laboratory findings to proven therapeutic claims, a milestone that could unlock broader distribution and attract larger strategic investors.